ArticleCureus2024
Biceps Tenodesis for the Treatment of Type II Superior Labral Anterior Posterior (SLAP) Tears in Overhead Athletes Under the Age of 35: A Case Series.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe best treatment for type II superior labral anterior posterior (SLAP) tears in overhead athletes is not well defined. QUESTIONS/PURPOSE: The purpose of this study was to examine post-surgical outcomes in overhead athletes under the age of 35 who underwent primary biceps tenodesis for an isolated type II SLAP tear. We hypothesized that these patients would have high rates of return to play, as well as recovery of range of motion (ROM) and strength after surgery. PATIENTS AND
methodsPatients were between the ages of 18 and 35, had a primary isolated type II SLAP tear confirmed on magnetic resonance imaging (MRI), and were injured performing overhead activities. All patients underwent biceps tenodesis using an arthroscopic suprapectoral approach. Patients underwent standard postoperative rehabilitation lasting up to one year. Function and outcomes were measured at baseline, three months, six months, one year, and two years using range of motion, strength testing, and patient-reported outcomes (PROs) (Western Ontario Shoulder Instability Index (WOSI), Kerlan-Jobe Orthopedic Clinic Score (KJOC), American Shoulder and Elbow Surgeons Assessment Form (ASES), and Single Assessment Numeric Evaluation (SANE)).
resultsFive patients were included in the case series. There was consistent improvement at each time point on PROs: WOSI, p=0.01; KJOC, p=0.04; SANE, p=0.02; and ASES, p=0.03. Range of motion increased from baseline to each time point with a significant improvement in forward flexion (p=0.03). In strength testing, there were improvements in all exercises and a significant improvement in abducted external rotation between years 1 and 2 (p<0.01).
conclusionsThis study demonstrated that biceps tenodesis in overhead athletes under the age of 35 provides improved outcomes, ROM, and strength.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.